Companies that own MediGene AG
Aviva Investors Global Services Ltd.
1,277,907
5.2%
-22,521
0.04%
08/28/2018
QVT Financial LP
1,072,879
4.37%
0
4.55%
05/30/2018
BlackRock Asset Management Deutschland AG
343,944
1.4%
0
0.01%
09/07/2018
Credit Suisse Asset Management (Schweiz) AG
293,000
1.19%
0
0.01%
06/29/2018
DWS Investment GmbH
293,000
1.19%
-13,000
0%
07/31/2018
Dimensional Fund Advisors LP
156,813
0.64%
51,665
0%
04/30/2018
Hauck & Aufhäuser Investment Gesellschaft SA
88,000
0.36%
88,000
0.17%
02/28/2018
GROHMANN & WEINRAUTER Institutional Asset Management GmbH
38,896
0.16%
1,812
1.02%
06/29/2018
LBBW Asset Management Investmentgesellschaft mbH
37,000
0.15%
4,000
0.01%
06/29/2018
Andreas Meißner Vermögensmanagement GmbH
27,000
0.11%
0
0.24%
06/29/2018
| Address |
Lochhamer Straße 11
Martinsried Bayern (Bavaria) 82152
Germany
|
|
Employees
|
- |
| Website |
http://www.medigene.de |
| Updated |
07/08/2019 |
| MediGene AG is a biotechnology company, which engages in developing innovative, complementary treatment platforms that target various types and stages of cancer. It focuses on the development of personalized T-cell based immunotherapies. It operates through the Immunotherapies and Other products segments. |
